drugset / Trial / NCT06916169
A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.
Timeline
- Start
- 2025-08
- Primary completion
- 2025-09
- Completion
- 2025-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AG2304 | Unknown | — | Oral |
| Subject | AG23041 | Unknown | — | Oral |
| Subject | AG23042 | Unknown | — | Oral |
Indications
No indication recorded.